StockNews.AI
HAE
StockNews.AI
194 days

Haemonetics 3rd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website

1. Haemonetics will release Q3 FY2025 results on February 6, 2025. 2. A conference call will allow discussions on financial performance. 3. Earnings release is available via their Investor Relations website. 4. Haemonetics focuses on innovative medical products to optimize patient care. 5. Awareness of financials could influence HAE stock performance.

Earnings
-14.49%Current Return
VS
-0.32%S&P 500
$71.2402/06 06:03 AM EDTEvent Start
$60.9201202/07 12:12 PM EDTLatest Updated
5m saved
Insight
Article

FAQ

Why Neutral?

Upcoming earnings calls often lead to volatility, but no strong indicators exist yet.

How important is it?

Earnings announcements usually affect stock prices significantly, hence a moderate score.

Why Short Term?

Immediate impact expected around earnings release, but long-term effects depend on results.

Related Companies

HAEXYLBSX
Financial release accessible online, /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its third quarter fiscal year 2025, which ended December 28, 2024, are available on its Investor Relations website.The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on February 6, 2025. The conference call and webcast can be accessed with the following information: Teleconference link: https://register.vevent.com/register/BIda08929a4d56464eb33eccb945ef985e Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start. A live webcast of the call can be accessed on Haemonetics' investor relations website or via the following link: https://edge.media-server.com/mmc/p/63jte4ra In addition, the Company has posted to its Investor Relations website the earnings release that will be referenced on its conference call and webcast, a link to which is available below. Direct link to 3Q FY25 Earnings Release: https://haemonetics.gcs-web.com/static-files/36134646-a371-4076-87b9-26673f9f10f3A replay of the conference call and webcast will be available for one year beginning on February 6, 2025, at 11:00 a.m. ET using the conference call webcast link provided in this press release.ABOUT HAEMONETICS Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com. Investor Contacts:                                                      Olga Guyette, Vice President-Investor Relations & Treasury      David Trenk, Manager-Investor Relations (781) 356-9763                                                      (203) 733-4987 [email protected]                            [email protected]   Media Contact:    Josh Gitelson, Sr. Director-Global Communications        (781) 356-9776 [email protected]  SOURCE Haemonetics Corporation WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News